Company · CIK 0001035354 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Eloxx Pharmaceuticals, Inc. · ELOX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 JForm 4 → | Jun 17, 5:15 pm EDT | Domicilium Real Estate Fund III LP10% Owner | 600,000 | — | — | 361,578 | — | late |
| May 27, 2026 JForm 4 → | Jun 5, 10:44 am EDT | Domicilium Real Estate Fund III LP10% Owner | 113,636 | — | — | 0 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 JForm 4 → | Jun 17, 5:15 pm EDT | Domicilium Real Estate Fund III LP10% Owner | 600,000 | — | — | 834,489 | — | late |
| Jun 10, 2026 AForm 4 → | Jun 10, 8:00 pm EDT | Sumit AggarwalPresident and CEO, Director | 328,833 | — | — | 328,833 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 8:00 pm EDT | Stephen W WebsterDirector | 13,587 | — | — | 13,587 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 8:00 pm EDT | Alan Edmund WaltsDirector | 8,590 | — | — | 8,590 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 8:00 pm EDT | Nina S KjellsonDirector | 13,587 | — | — | 13,587 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 8:00 pm EDT | Steven D RubinDirector | 4,018 | — | — | 4,018 | — | |
| May 27, 2026 JForm 4 → | Jun 5, 10:44 am EDT | Domicilium Real Estate Fund III LP10% Owner | 113,636 | — | — | 238,422 | — | late |